Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Other Working Capital Changes (2016 - 2025)

IGC Pharma (IGC) has disclosed Other Working Capital Changes for 16 consecutive years, with -$1.1 million as the latest value for Q3 2025.

  • Quarterly Other Working Capital Changes fell 544.91% to -$1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$843000.0 through Sep 2025, down 620.51% year-over-year, with the annual reading at $187000.0 for FY2025, 244.96% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$1.1 million at IGC Pharma, down from -$2000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $2.2 million in Q1 2021, with the low at -$1.1 million in Q3 2025.
  • Average Other Working Capital Changes over 5 years is $2368.4, with a median of -$28000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes surged 1603.88% in 2021, then plummeted 1725.0% in 2022.
  • Over 5 years, Other Working Capital Changes stood at $36000.0 in 2021, then tumbled by 438.89% to -$122000.0 in 2022, then soared by 74.59% to -$31000.0 in 2023, then skyrocketed by 870.97% to $239000.0 in 2024, then plummeted by 550.63% to -$1.1 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.1 million, -$2000.0, and -$3000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.